Published in Cancer Res on June 02, 2009
Recent adverse trends in semen quality and testis cancer incidence among Finnish men. Int J Androl (2011) 1.96
OCT2, SSX and SAGE1 reveal the phenotypic heterogeneity of spermatocytic seminoma reflecting distinct subpopulations of spermatogonia. J Pathol (2011) 1.59
Etiologic factors in testicular germ-cell tumors. Future Oncol (2009) 1.44
Developmental reprogramming of cancer susceptibility. Nat Rev Cancer (2012) 1.35
Custom human endogenous retroviruses dedicated microarray identifies self-induced HERV-W family elements reactivated in testicular cancer upon methylation control. Nucleic Acids Res (2010) 1.07
Male reproductive disorders, diseases, and costs of exposure to endocrine-disrupting chemicals in the European Union. J Clin Endocrinol Metab (2015) 0.99
Organochlorine compounds and testicular dysgenesis syndrome: human data. Int J Androl (2011) 0.97
A genome-wide association study of men with symptoms of testicular dysgenesis syndrome and its network biology interpretation. J Med Genet (2011) 0.96
Male Reproductive Disorders and Fertility Trends: Influences of Environment and Genetic Susceptibility. Physiol Rev (2016) 0.96
Carcinoma in situ testis displays permissive chromatin modifications similar to immature foetal germ cells. Br J Cancer (2010) 0.94
NANOG promoter methylation and expression correlation during normal and malignant human germ cell development. Epigenetics (2011) 0.94
Evidence that active demethylation mechanisms maintain the genome of carcinoma in situ cells hypomethylated in the adult testis. Br J Cancer (2013) 0.93
Analysis of SOX2 expression in developing human testis and germ cell neoplasia. Int J Dev Biol (2010) 0.88
Optimizing staining protocols for laser microdissection of specific cell types from the testis including carcinoma in situ. PLoS One (2009) 0.88
A unique combination of male germ cell miRNAs coordinates gonocyte differentiation. PLoS One (2012) 0.87
Retinoblastoma protein (RB1) controls fate determination in stem cells and progenitors of the mouse male germline. Biol Reprod (2013) 0.86
Testicular cancer: biology and biomarkers. Virchows Arch (2014) 0.86
Induction and persistence of abnormal testicular germ cells following gestational exposure to di-(n-butyl) phthalate in p53-null mice. J Androl (2011) 0.83
Vitamin D metabolism and effects on pluripotency genes and cell differentiation in testicular germ cell tumors in vitro and in vivo. Neoplasia (2012) 0.83
Cellular and molecular effect of MEHP Involving LXRα in human fetal testis and ovary. PLoS One (2012) 0.82
Pathway-based analysis of GWAs data identifies association of sex determination genes with susceptibility to testicular germ cell tumors. Hum Mol Genet (2014) 0.82
Intratubular germ cell neoplasms of the testis and bilateral testicular tumors: clinical significance and management options. Indian J Urol (2010) 0.81
An alkylphenol mix promotes seminoma derived cell proliferation through an ERalpha36-mediated mechanism. PLoS One (2013) 0.81
Laser capture microdissection of gonads from juvenile zebrafish. Reprod Biol Endocrinol (2009) 0.81
The cancer/testis-antigen PRAME supports the pluripotency network and represses somatic and germ cell differentiation programs in seminomas. Br J Cancer (2016) 0.80
Aza-deoxycytidine induces apoptosis or differentiation via DNMT3B and targets embryonal carcinoma cells but not their differentiated derivatives. Br J Cancer (2014) 0.79
Significant calendar period deviations in testicular germ cell tumors indicate that postnatal exposures are etiologically relevant. Cancer Causes Control (2012) 0.78
Genomic evolution and chemoresistance in germ-cell tumours. Nature (2016) 0.78
Transcriptome profiling of mice testes following low dose irradiation. Reprod Biol Endocrinol (2013) 0.77
Clinical observations on chemotherapy curable malignancies: unique genetic events, frozen development and enduring apoptotic potential. BMC Cancer (2015) 0.76
The Homeobox Transcription Factor RHOX10 Drives Mouse Spermatogonial Stem Cell Establishment. Cell Rep (2016) 0.76
The plasticity of germ cell cancers and its dependence on the cellular microenvironment. J Cell Mol Med (2017) 0.75
Current Management of Undescended Testes. Curr Treat Options Pediatr (2016) 0.75
Germ cell tumors: Insights from the Drosophila ovary and the mouse testis. Mol Reprod Dev (2017) 0.75
Imprints and DPPA3 are bypassed during pluripotency- and differentiation-coupled methylation reprogramming in testicular germ cell tumors. Genome Res (2016) 0.75
A signaling cascade including ARID1A, GADD45B and DUSP1 induces apoptosis and affects the cell cycle of germ cell cancers after romidepsin treatment. Oncotarget (2016) 0.75
Involvement of the DNA mismatch repair system in cisplatin sensitivity of testicular germ cell tumours. Cell Oncol (Dordr) (2017) 0.75
Meta-analysis of five genome-wide association studies identifies multiple new loci associated with testicular germ cell tumor. Nat Genet (2017) 0.75
The role of vitamin D in male fertility: A focus on the testis. Rev Endocr Metab Disord (2017) 0.75
Spontaneous CD4(+) and CD8(+) T cell responses directed against cancer testis antigens are present in the peripheral blood of testicular cancer patients. Eur J Immunol (2017) 0.75
Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A (2001) 132.88
TM4: a free, open-source system for microarray data management and analysis. Biotechniques (2003) 38.02
Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat Biotechnol (2003) 9.15
Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum Reprod (2001) 7.25
Retracted Generation of pluripotent stem cells from adult human testis. Nature (2008) 5.49
Subcellular compartmentation and differential catalytic properties of the three human nicotinamide mononucleotide adenylyltransferase isoforms. J Biol Chem (2005) 2.71
Possible carcinoma-in-situ of the testis. Lancet (1972) 2.68
POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res (2003) 2.45
Germ cell tumors in the intersex gonad: old paths, new directions, moving frontiers. Endocr Rev (2006) 2.40
Testicular dysgenesis syndrome: mechanistic insights and potential new downstream effects. Fertil Steril (2008) 1.96
Genetics and biology of adult human male germ cell tumors. Cancer Res (2000) 1.66
Embryonic stem cell-like features of testicular carcinoma in situ revealed by genome-wide gene expression profiling. Cancer Res (2004) 1.56
Multiclass classification of microarray data with repeated measurements: application to cancer. Genome Biol (2003) 1.55
Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal development. Cancer Res (2005) 1.52
Pathobiological implications of the expression of markers of testicular carcinoma in situ by fetal germ cells. J Pathol (2004) 1.47
Stem cell pluripotency factor NANOG is expressed in human fetal gonocytes, testicular carcinoma in situ and germ cell tumours. Histopathology (2005) 1.45
Developmental expression of POU5F1 (OCT-3/4) in normal and dysgenetic human gonads. Hum Reprod (2004) 1.34
Co-expression of cytokeratin and vimentin filaments in mesothelial, granulosa and rete ovarii cells of the human ovary. Eur J Cell Biol (1985) 1.33
Expression of anti-Müllerian hormone during normal and pathological gonadal development: association with differentiation of Sertoli and granulosa cells. J Clin Endocrinol Metab (1999) 1.29
FOXL2 and SOX9 as parameters of female and male gonadal differentiation in patients with various forms of disorders of sex development (DSD). J Pathol (2008) 1.29
Transcription factor AP-2gamma is a developmentally regulated marker of testicular carcinoma in situ and germ cell tumors. Clin Cancer Res (2004) 1.27
Carcinoma-in-situ of the undescended testis. Urol Clin North Am (1982) 1.26
The emerging phenotype of the testicular carcinoma in situ germ cell. APMIS (2003) 1.24
Expression of immunohistochemical markers for testicular carcinoma in situ by normal human fetal germ cells. Lab Invest (1995) 1.17
Identification and characterization of ASXL3 gene in silico. Int J Oncol (2004) 1.15
The stem cell identity of testicular cancer. Stem Cell Rev (2007) 1.14
Identity of M2A (D2-40) antigen and gp36 (Aggrus, T1A-2, podoplanin) in human developing testis, testicular carcinoma in situ and germ-cell tumours. Virchows Arch (2006) 1.07
Carcinoma in situ in the testis. Scand J Urol Nephrol Suppl (2000) 1.05
Intermediate filament proteins in human testis and testicular germ-cell tumors. Am J Pathol (1985) 1.04
Expression of protamine-1 and -2 mRNA during human spermiogenesis. Mol Hum Reprod (2000) 1.02
Role of gain of 12p in germ cell tumour development. APMIS (2003) 1.01
Placental alkaline phosphatase in testicular germ cell tumours and in carcinoma-in-situ of the testis. An immunohistochemical study. Acta Pathol Microbiol Immunol Scand A (1984) 1.01
Identification, characterization, and evolution of a primate beta-defensin gene cluster. Genes Immun (2005) 1.00
Genome profiles of familial/bilateral and sporadic testicular germ cell tumors. Genes Chromosomes Cancer (2002) 0.99
Gene expression profiling identifies new biological markers of neoplastic germ cells. Anticancer Res (2007) 0.96
Developmental changes in human fetal testicular cell numbers and messenger ribonucleic acid levels during the second trimester. J Clin Endocrinol Metab (2007) 0.95
Early manifestations of testicular dysgenesis in children: pathological phenotypes, karyotype correlations and precursor stages of tumour development. APMIS (2003) 0.94
Overrepresentation of the short arm of chromosome 12 is related to invasive growth of human testicular seminomas and nonseminomas. Oncogene (2000) 0.93
Testicular dysgenesis syndrome and the origin of carcinoma in situ testis. Int J Androl (2008) 0.93
High-resolution comparative genomic hybridization detects extra chromosome arm 12p material in most cases of carcinoma in situ adjacent to overt germ cell tumors, but not before the invasive tumor development. Genes Chromosomes Cancer (2003) 0.91
Germ cell differentiation-dependent and stage-specific expression of LANCL1 in rodent testis. Eur J Histochem (2003) 0.88
Optimizing staining protocols for laser microdissection of specific cell types from the testis including carcinoma in situ. PLoS One (2009) 0.88
Fetal antigen 1, an EGF multidomain protein in the sex hormone-producing cells of the gonads and the microenvironment of germ cells. Mol Hum Reprod (1999) 0.87
Dysfunction of the mitotic:meiotic switch as a potential cause of neoplastic conversion of primordial germ cells. Int J Androl (2006) 0.87
A monoclonal antibody as a marker for carcinoma in situ germ cells of the human adult testis. APMIS (1988) 0.85
Aneuploidy as a marker for carcinoma-in-situ of the testis. Acta Pathol Microbiol Scand A (1981) 0.84
A receptor-type protein tyrosine phosphatase PTP zeta is expressed in human cutaneous melanomas. Folia Histochem Cytobiol (2000) 0.81
Light and electron microscopical analysis of cell types in human seminoma. Virchows Arch A Pathol Anat Histol (1974) 0.81
Anti-MIC2 as a tool in examination of testicular biopsies. APMIS (1999) 0.77
Improved prediction of signal peptides: SignalP 3.0. J Mol Biol (2004) 48.40
A human gut microbial gene catalogue established by metagenomic sequencing. Nature (2010) 43.63
SignalP 4.0: discriminating signal peptides from transmembrane regions. Nat Methods (2011) 33.90
Enterotypes of the human gut microbiome. Nature (2011) 24.36
Locating proteins in the cell using TargetP, SignalP and related tools. Nat Protoc (2007) 19.50
A human phenome-interactome network of protein complexes implicated in genetic disorders. Nat Biotechnol (2007) 9.90
Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat Biotechnol (2007) 9.36
Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat Biotechnol (2003) 9.15
Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci Signal (2010) 8.61
Prediction of post-translational glycosylation and phosphorylation of proteins from the amino acid sequence. Proteomics (2004) 7.76
Ancient human genome sequence of an extinct Palaeo-Eskimo. Nature (2010) 7.51
A new non-linear normalization method for reducing variability in DNA microarray experiments. Genome Biol (2002) 7.12
Richness of human gut microbiome correlates with metabolic markers. Nature (2013) 6.93
Prediction of lipoprotein signal peptides in Gram-negative bacteria. Protein Sci (2003) 6.85
Prediction, conservation analysis, and structural characterization of mammalian mucin-type O-glycosylation sites. Glycobiology (2004) 6.13
Reliable prediction of T-cell epitopes using neural networks with novel sequence representations. Protein Sci (2003) 5.94
Analysis and prediction of leucine-rich nuclear export signals. Protein Eng Des Sel (2004) 5.15
Dynamic complex formation during the yeast cell cycle. Science (2005) 5.11
The timing of normal puberty and the age limits of sexual precocity: variations around the world, secular trends, and changes after migration. Endocr Rev (2003) 4.88
An Aboriginal Australian genome reveals separate human dispersals into Asia. Science (2011) 4.84
Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors. Proc Natl Acad Sci U S A (2003) 4.67
Feature-based prediction of non-classical and leaderless protein secretion. Protein Eng Des Sel (2004) 4.54
Adaptation to culture of human embryonic stem cells and oncogenesis in vivo. Nat Biotechnol (2007) 4.53
Mining electronic health records: towards better research applications and clinical care. Nat Rev Genet (2012) 4.42
Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol (2005) 4.27
Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nat Biotechnol (2011) 3.97
The implications of alternative splicing in the ENCODE protein complement. Proc Natl Acad Sci U S A (2007) 3.93
Linear motif atlas for phosphorylation-dependent signaling. Sci Signal (2008) 3.77
Improved prediction of MHC class I and class II epitopes using a novel Gibbs sampling approach. Bioinformatics (2004) 3.72
A large-scale analysis of tissue-specific pathology and gene expression of human disease genes and complexes. Proc Natl Acad Sci U S A (2008) 3.57
Recalibrating Equus evolution using the genome sequence of an early Middle Pleistocene horse. Nature (2013) 3.45
Clustering patterns of cytotoxic T-lymphocyte epitopes in human immunodeficiency virus type 1 (HIV-1) proteins reveal imprints of immune evasion on HIV-1 global variation. J Virol (2002) 3.38
Optimization of oligonucleotide-based DNA microarrays. Nucleic Acids Res (2002) 3.36
Co-evolution of transcriptional and post-translational cell-cycle regulation. Nature (2006) 3.28
High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity. Nat Biotechnol (2010) 3.21
Non-classical protein secretion in bacteria. BMC Microbiol (2005) 3.17
Prediction of proprotein convertase cleavage sites. Protein Eng Des Sel (2004) 3.05
Prediction of twin-arginine signal peptides. BMC Bioinformatics (2005) 3.03
Stem cell states, fates, and the rules of attraction. Cell Stem Cell (2009) 2.96
Low-dose irradiation programs macrophage differentiation to an iNOS⁺/M1 phenotype that orchestrates effective T cell immunotherapy. Cancer Cell (2013) 2.89
Comparison of computational methods for the identification of cell cycle-regulated genes. Bioinformatics (2004) 2.83
Human breast milk contamination with phthalates and alterations of endogenous reproductive hormones in infants three months of age. Environ Health Perspect (2006) 2.73
Cellular differentiation hierarchies in normal and culture-adapted human embryonic stem cells. Hum Mol Genet (2005) 2.66
Precision mapping of the human O-GalNAc glycoproteome through SimpleCell technology. EMBO J (2013) 2.58
Surface antigens of human embryonic stem cells: changes upon differentiation in culture. J Anat (2002) 2.52
Specific knockdown of Oct4 and beta2-microglobulin expression by RNA interference in human embryonic stem cells and embryonic carcinoma cells. Stem Cells (2004) 2.52
Metagenomic species profiling using universal phylogenetic marker genes. Nat Methods (2013) 2.51
Growth-rate regulated genes have profound impact on interpretation of transcriptome profiling in Saccharomyces cerevisiae. Genome Biol (2006) 2.43
Body mass index in relation to semen quality and reproductive hormones among 1,558 Danish men. Fertil Steril (2004) 2.40
Definition of supertypes for HLA molecules using clustering of specificity matrices. Immunogenetics (2004) 2.39
LIF/STAT3 signaling fails to maintain self-renewal of human embryonic stem cells. Stem Cells (2004) 2.37
Pigs in sequence space: a 0.66X coverage pig genome survey based on shotgun sequencing. BMC Genomics (2005) 2.34
Prediction of glycosylation across the human proteome and the correlation to protein function. Pac Symp Biocomput (2002) 2.29
A nondegenerate code of deleterious variants in Mendelian loci contributes to complex disease risk. Cell (2013) 2.28
Public health implications of altered puberty timing. Pediatrics (2008) 2.26
Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis. J Exp Med (2005) 2.25
ATM activation in normal human tissues and testicular cancer. Cell Cycle (2005) 2.25
Alternative splicing in colon, bladder, and prostate cancer identified by exon array analysis. Mol Cell Proteomics (2008) 2.24
NESbase version 1.0: a database of nuclear export signals. Nucleic Acids Res (2003) 2.21
European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I. Eur Urol (2007) 2.21
An integrative approach to CTL epitope prediction: a combined algorithm integrating MHC class I binding, TAP transport efficiency, and proteasomal cleavage predictions. Eur J Immunol (2005) 2.19
Using electronic patient records to discover disease correlations and stratify patient cohorts. PLoS Comput Biol (2011) 2.14
Recent decline in age at breast development: the Copenhagen Puberty Study. Pediatrics (2009) 2.09
Cryptorchidism and hypospadias as a sign of testicular dysgenesis syndrome (TDS): environmental connection. Birth Defects Res A Clin Mol Teratol (2010) 2.04
Human semen quality in the new millennium: a prospective cross-sectional population-based study of 4867 men. BMJ Open (2012) 2.03
Vitamin D receptor and vitamin D metabolizing enzymes are expressed in the human male reproductive tract. Hum Reprod (2010) 2.00
Intrauterine exposure to mild analgesics is a risk factor for development of male reproductive disorders in human and rat. Hum Reprod (2010) 1.97
Testicular dysgenesis syndrome: mechanistic insights and potential new downstream effects. Fertil Steril (2008) 1.96
OCT4 spliced variants are differentially expressed in human pluripotent and nonpluripotent cells. Stem Cells (2008) 1.95
Modeling the adaptive immune system: predictions and simulations. Bioinformatics (2007) 1.95
Endostatin's antiangiogenic signaling network. Mol Cell (2004) 1.95
Transient and stable transgene expression in human embryonic stem cells. Stem Cells (2007) 1.91
East-West gradient in semen quality in the Nordic-Baltic area: a study of men from the general population in Denmark, Norway, Estonia and Finland. Hum Reprod (2002) 1.91
Transcriptional switch of dormant tumors to fast-growing angiogenic phenotype. Cancer Res (2009) 1.90
Reversible infertility in male mice after oral administration of alkylated imino sugars: a nonhormonal approach to male contraception. Proc Natl Acad Sci U S A (2002) 1.88
Human gut microbes impact host serum metabolome and insulin sensitivity. Nature (2016) 1.85
Transcriptional network governing the angiogenic switch in human pancreatic cancer. Proc Natl Acad Sci U S A (2007) 1.85
Restoration of auditory evoked responses by human ES-cell-derived otic progenitors. Nature (2012) 1.83
Culture and characterization of human embryonic stem cells. Stem Cells Dev (2004) 1.82
Heparin promotes the growth of human embryonic stem cells in a defined serum-free medium. Proc Natl Acad Sci U S A (2008) 1.82
Prediction of proteasome cleavage motifs by neural networks. Protein Eng (2002) 1.81